• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Quality control and reference guidelines for CLSI broth microdilution method (M38-A document) for susceptibility testing of anidulafungin against molds.针对阿尼芬净对霉菌药敏试验的CLSI肉汤微量稀释法(M38-A文件)的质量控制和参考指南。
J Clin Microbiol. 2007 Jul;45(7):2180-2. doi: 10.1128/JCM.00399-07. Epub 2007 May 2.
2
Quality control and reference guidelines for CLSI broth microdilution susceptibility method (M 38-A document) for amphotericin B, itraconazole, posaconazole, and voriconazole.两性霉素B、伊曲康唑、泊沙康唑和伏立康唑的CLSI肉汤微量稀释药敏试验方法(M 38 - A文件)的质量控制与参考指南。
J Clin Microbiol. 2005 Oct;43(10):5243-6. doi: 10.1128/JCM.43.10.5243-5246.2005.
3
Comparison of the E-test with the NCCLS M38-P method for antifungal susceptibility testing of common and emerging pathogenic filamentous fungi.E-test法与NCCLS M38-P法用于常见和新出现的致病性丝状真菌抗真菌药敏试验的比较。
J Clin Microbiol. 2001 Apr;39(4):1360-7. doi: 10.1128/JCM.39.4.1360-1367.2001.
4
Multicenter evaluation of a new disk agar diffusion method for susceptibility testing of filamentous fungi with voriconazole, posaconazole, itraconazole, amphotericin B, and caspofungin.一种用于丝状真菌对伏立康唑、泊沙康唑、伊曲康唑、两性霉素B和卡泊芬净药敏试验的新型纸片琼脂扩散法的多中心评估
J Clin Microbiol. 2007 Jun;45(6):1811-20. doi: 10.1128/JCM.00134-07. Epub 2007 Apr 11.
5
In vitro fungicidal activities of voriconazole, itraconazole, and amphotericin B against opportunistic moniliaceous and dematiaceous fungi.伏立康唑、伊曲康唑和两性霉素B对机会性念珠菌和暗色真菌的体外杀真菌活性。
J Clin Microbiol. 2001 Mar;39(3):954-8. doi: 10.1128/JCM.39.3.954-958.2001.
6
Initial results from a longitudinal international surveillance programme for anidulafungin (2003).阿尼芬净纵向国际监测项目的初步结果(2003年)
J Antimicrob Chemother. 2004 Dec;54(6):1051-6. doi: 10.1093/jac/dkh504. Epub 2004 Nov 25.
7
Trends in antifungal susceptibility testing using CLSI reference and commercial methods.采用美国临床和实验室标准协会(CLSI)参考方法及商业方法进行抗真菌药敏试验的趋势。
Expert Rev Anti Infect Ther. 2009 Feb;7(1):107-19. doi: 10.1586/14787210.7.1.107.
8
Interlaboratory study of quality control isolates for a broth microdilution method (modified CLSI M38-A) for testing susceptibilities of dermatophytes to antifungals.用于检测皮肤癣菌对抗真菌药物敏感性的肉汤微量稀释法(改良的CLSI M38-A)的质量控制菌株的实验室间研究。
J Clin Microbiol. 2006 Dec;44(12):4353-6. doi: 10.1128/JCM.00688-06. Epub 2006 Oct 18.
9
Evaluation of the Etest method for susceptibility testing of Aspergillus spp. and Fusarium spp. to three echinocandins.评估 Etest 法检测 Aspergillus spp. 和 Fusarium spp. 对三种棘白菌素类药物的敏感性。
Med Mycol. 2010 Sep;48(6):858-61. doi: 10.3109/13693781003586943.
10
Antifungal susceptibility testing method for resource constrained laboratories.资源有限实验室的抗真菌药敏试验方法
Indian J Med Microbiol. 2006 Jul;24(3):171-6.

引用本文的文献

1
Causative Agents of Fungal Keratitis in Northeastern Iran: A 3-Year Tertiary Care Hospital Study.伊朗东北部真菌性角膜炎的病原体:一项为期三年的三级护理医院研究
Am J Trop Med Hyg. 2024 Dec 17;112(3):553-560. doi: 10.4269/ajtmh.24-0046. Print 2025 Mar 5.
2
Analysis of Mannose-Binding Lectin Protein Levels and their MIC Profile in Patients with Dermatophytosis.皮肤癣菌病患者甘露糖结合凝集素蛋白水平及其MIC谱分析。
Indian Dermatol Online J. 2022 Jul 18;14(1):94-96. doi: 10.4103/idoj.idoj_725_21. eCollection 2023 Jan-Feb.
3
Antimicrobial activity and bioactive profiling of heterocytous cyanobacterial strains using MS/MS-based molecular networking.利用基于 MS/MS 的分子网络技术研究异形胞蓝藻菌株的抗菌活性和生物活性特征。
Folia Microbiol (Praha). 2019 Sep;64(5):645-654. doi: 10.1007/s12223-019-00737-9. Epub 2019 Aug 5.
4
Application of HPCCC Combined with Polymeric Resins and HPLC for the Separation of Cyclic Lipopeptides Muscotoxins A⁻C and Their Antimicrobial Activity.高速逆流色谱结合高分子树脂与高效液相色谱联用技术分离环状脂肽类化合物 moscotoxin A⁻C 及其抑菌活性
Molecules. 2018 Oct 16;23(10):2653. doi: 10.3390/molecules23102653.
5
Phylogenetic Diversity and In Vitro Susceptibility Profiles of Human Pathogenic Members of the Fusarium fujikuroi Species Complex Isolated from South India.从印度南部分离的人类致病尖孢镰刀菌种复合体成员的系统发育多样性和体外药敏谱。
Mycopathologia. 2018 Jun;183(3):529-540. doi: 10.1007/s11046-018-0248-7. Epub 2018 Feb 14.
6
Antifungal activity of Cleome gynandra L. aerial parts for topical treatment of Tinea capitis: an in vitro evaluation.白花菜地上部分对头皮癣局部治疗的抗真菌活性:体外评价
BMC Complement Altern Med. 2016 Jul 8;16:194. doi: 10.1186/s12906-016-1187-9.
7
N-myristoyltransferase is a cell wall target in Aspergillus fumigatus.N-肉豆蔻酰转移酶是烟曲霉细胞壁的一个靶点。
ACS Chem Biol. 2015 Jun 19;10(6):1425-34. doi: 10.1021/cb5008647. Epub 2015 Feb 27.
8
New furanones from the plant endophytic fungus Pestalotiopsis besseyi.植物内生真菌拟盘多毛孢中新的呋喃酮类化合物。
Molecules. 2012 Nov 27;17(12):14015-21. doi: 10.3390/molecules171214015.
9
Caspofungin affects growth of Paracoccidioides brasiliensis in both morphological phases.卡泊芬净影响巴西副球孢子菌在两种形态阶段的生长。
Antimicrob Agents Chemother. 2010 Dec;54(12):5391-4. doi: 10.1128/AAC.00617-10. Epub 2010 Oct 11.
10
Potency of anidulafungin compared to nine other antifungal agents tested against Candida spp., Cryptococcus spp., and Aspergillus spp.: results from the global SENTRY Antimicrobial Surveillance Program (2008).比较了棘白菌素类药物(阿尼芬净)与其他 9 种抗真菌药物对念珠菌属、隐球菌属和曲霉菌属的体外抗菌活性:全球 SENTRY 抗菌药物监测计划(2008 年)的结果。
J Clin Microbiol. 2010 Aug;48(8):2984-7. doi: 10.1128/JCM.00328-10. Epub 2010 Jun 9.

本文引用的文献

1
Quality control and reference guidelines for CLSI broth microdilution susceptibility method (M 38-A document) for amphotericin B, itraconazole, posaconazole, and voriconazole.两性霉素B、伊曲康唑、泊沙康唑和伏立康唑的CLSI肉汤微量稀释药敏试验方法(M 38 - A文件)的质量控制与参考指南。
J Clin Microbiol. 2005 Oct;43(10):5243-6. doi: 10.1128/JCM.43.10.5243-5246.2005.
2
In vitro antifungal activities of anidulafungin and micafungin, licensed agents and the investigational triazole posaconazole as determined by NCCLS methods for 12,052 fungal isolates: review of the literature.通过美国国家临床实验室标准委员会(NCCLS)方法测定的阿尼芬净、米卡芬净(已获许可的药物)及研究性三唑类药物泊沙康唑对12052株真菌分离株的体外抗真菌活性:文献综述
Rev Iberoam Micol. 2003 Dec;20(4):121-36.
3
Interlaboratory comparison of results of susceptibility testing with caspofungin against Candida and Aspergillus species.实验室间对卡泊芬净对念珠菌属和曲霉属菌种药敏试验结果的比较。
J Clin Microbiol. 2004 Aug;42(8):3475-82. doi: 10.1128/JCM.42.8.3475-3482.2004.
4
Evaluation of broth microdilution testing parameters and agar diffusion Etest procedure for testing susceptibilities of Aspergillus spp. to caspofungin acetate (MK-0991).评价肉汤微量稀释法检测参数及琼脂扩散Etest法检测曲霉属对醋酸卡泊芬净(MK-0991)敏感性的方法。
J Clin Microbiol. 2003 Jan;41(1):403-9. doi: 10.1128/JCM.41.1.403-409.2003.
5
Optimal susceptibility testing conditions for detection of azole resistance in Aspergillus spp.: NCCLS collaborative evaluation. National Committee for Clinical Laboratory Standards.检测曲霉属中唑类耐药性的最佳药敏试验条件:NCCLS协作评估。美国国家临床实验室标准委员会
Antimicrob Agents Chemother. 2001 Jun;45(6):1828-35. doi: 10.1128/AAC.45.6.1828-1835.2001.
6
Comparison of In vitro activities of the new triazole SCH56592 and the echinocandins MK-0991 (L-743,872) and LY303366 against opportunistic filamentous and dimorphic fungi and yeasts.新型三唑类药物SCH56592与棘白菌素类药物MK-0991(L-743,872)和LY303366对机会性丝状真菌、双相真菌和酵母的体外活性比较。
J Clin Microbiol. 1998 Oct;36(10):2950-6. doi: 10.1128/JCM.36.10.2950-2956.1998.
7
Multicenter evaluation of proposed standardized procedure for antifungal susceptibility testing of filamentous fungi.丝状真菌抗真菌药敏试验标准化程序的多中心评估
J Clin Microbiol. 1997 Jan;35(1):139-43. doi: 10.1128/jcm.35.1.139-143.1997.

针对阿尼芬净对霉菌药敏试验的CLSI肉汤微量稀释法(M38-A文件)的质量控制和参考指南。

Quality control and reference guidelines for CLSI broth microdilution method (M38-A document) for susceptibility testing of anidulafungin against molds.

作者信息

Espinel-Ingroff A, Fothergill A, Ghannoum M, Manavathu E, Ostrosky-Zeichner L, Pfaller M A, Rinaldi M G, Schell W, Walsh T J

机构信息

VCU Medical Center, 1101 E. Marshall Street, Sanger Hall, Room 7-049, P.O. Box 980049, Richmond, VA 23298-0049, USA.

出版信息

J Clin Microbiol. 2007 Jul;45(7):2180-2. doi: 10.1128/JCM.00399-07. Epub 2007 May 2.

DOI:10.1128/JCM.00399-07
PMID:17475760
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1932988/
Abstract

The CLSI (formerly NCCLS) M38-A document for antifungal susceptibility testing of filamentous fungi does not describe guidelines for echinocandins. A multicenter study (eight centers) evaluated inter- and intralaboratory reproducibilities of two reading times (24 and 48 h or 48 and 72 h) and two end points (MICs and minimum effective concentrations [MECs]) for evaluating anidulafungin against molds. Anidulafungin MICs (>or=50% inhibition) and MECs (morphological hyphal changes) were determined for seven Aspergillus isolates (four species) and one isolate each of Fusarium moniliforme, Fusarium solani, and Paecilomyces variotii and for two Scedosporium apiospermum isolates. The inter- and intralaboratory reproducibilities of 10 replicate tests performed in each laboratory on 10 different days for each isolate was 100% at 24 h (MECs, <or=0.015 microg/ml) for six Aspergillus and P. variotii isolates. The reproducibility was 94 to 96.7% at 72 h (MECs, 1 to 8 microg/ml) for S. apiospermum and 96.7 to 97.5% at 48 h (MICs, >or=32 microg/ml) for both Fusarium isolates. Introduction of these identified optimum testing conditions for anidulafungin into future versions of the M38 document is warranted.

摘要

临床和实验室标准协会(原国家临床实验室标准委员会)关于丝状真菌抗真菌药敏试验的M38 - A文件未描述棘白菌素类药物的指导原则。一项多中心研究(八个中心)评估了两种读数时间(24小时和48小时或48小时和72小时)以及两种终点(最低抑菌浓度[MICs]和最低有效浓度[MECs])在评价阿尼芬净对霉菌作用时的实验室间和实验室内部的重复性。对七种曲霉分离株(四个种)、一株串珠镰刀菌、一株茄病镰刀菌、一株拟青霉以及两株尖端赛多孢分离株测定了阿尼芬净的MICs(≥50%抑制率)和MECs(形态学菌丝变化)。每个实验室在10个不同日期对每个分离株进行10次重复试验,对于六种曲霉和拟青霉分离株,在24小时时(MECs,≤0.015微克/毫升)实验室间和实验室内部的重复性为100%。对于尖端赛多孢,在72小时时(MECs,1至8微克/毫升)重复性为94%至96.7%,对于两种镰刀菌分离株,在48小时时(MICs,≥32微克/毫升)重复性为96.7%至97.5%。有必要将这些确定的阿尼芬净最佳试验条件纳入M38文件的未来版本中。